Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial - Concepedia

Concepedia

Publication | Closed Access

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

440

Citations

29

References

2003

Year

Daniel Betticher, Shu-Fang Hsu Schmitz, Martin Tötsch, Eva Støttrup Hansen, Christine Joss, Christian von Briel, Ralph A. Schmid, Miklos Pless, James Habicht, Arnaud Roth,

Journal of Clinical Oncology

Abstract

Neoadjuvant docetaxel-cisplatin is effective and tolerable in stage IIIA pN2 NSCLC. Resection is recommended only for patients with mediastinal downstaging after chemotherapy.

References

	Year	Citations

Page 1